From FDA reports: drug interactions between Unasyn, Famotidine, Cefazolin, Rocephin, Fentanyl Citrate for a Female patient aged 9

This is a personalized study of Unasyn, Famotidine, Cefazolin, Rocephin, Fentanyl Citrate drug interactions for a 9 year old female patient. The study is created by eHealthMe based on 4 reports from FDA.

Do you have a question? Healthcare is personal: one drug can work differently between women and men, or for people of different ages. How do you find patients like you to answer your question, and ensure only patients like you can answer it? Our Personalized Q&A can help. Start now

On May, 17, 2013: 4 people who reported to have interactions when taking Unasyn, Famotidine, Cefazolin, Rocephin, Fentanyl Citrate are studied

Information of the patient in this study:

Age: 9

Gender: female

Conditions: Pneumonia, Prophylaxis

Drugs taking:
- Unasyn: used for < 1 month
- Famotidine: used for < 1 month
- Cefazolin: used for < 1 month
- Rocephin
- Fentanyl Citrate

Drug interactions have: Acute Respiratory Distress Syndrome, Hypersensitivity, Pneumonia Aspiration, Pulmonary Oedema, Staphylococcal Infection

eHealthMe real world results:

For females aged 9 (±5):

Comparison with this patient's adverse outcomes:

Most common interactions experienced by females aged 9 (±5) in the use of Unasyn, Famotidine, Cefazolin, Rocephin, Fentanyl Citrate:

Login or sign up (it's free) to view more results. Or personalize this study

Most common interactions experienced by females aged 9 (±5) in long term use of Unasyn, Famotidine, Cefazolin, Rocephin, Fentanyl Citrate:

For people in general (regardless of gender or age):

Comparison with this patient's adverse outcomes:

Most common interactions experienced by people in the use of Unasyn, Famotidine, Cefazolin, Rocephin, Fentanyl Citrate:

Login or sign up (it's free) to view more results. Or personalize this study

Most common interactions experienced by people in long term use of Unasyn, Famotidine, Cefazolin, Rocephin, Fentanyl Citrate:

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Next: study your drugs OR ask a question from Patients Like You

In-depth study of side effects (who have it, when it happens and how):

• Acute Respiratory Distress Syndrome (ARDS (acute respiratory distress syndrome)) in Unasyn (50 reports)
• Acute Respiratory Distress Syndrome (ARDS (acute respiratory distress syndrome)) in Famotidine (172 reports)
• Acute Respiratory Distress Syndrome (ARDS (acute respiratory distress syndrome)) in Cefazolin (51 reports)
• Acute Respiratory Distress Syndrome (ARDS (acute respiratory distress syndrome)) in Rocephin (111 reports)
• Acute Respiratory Distress Syndrome (ARDS (acute respiratory distress syndrome)) in Fentanyl Citrate (38 reports)
• Hypersensitivity in Unasyn (60 reports)
• Hypersensitivity in Famotidine (197 reports)
• Hypersensitivity in Cefazolin (62 reports)
• Hypersensitivity in Rocephin (197 reports)
• Hypersensitivity in Fentanyl Citrate (41 reports)
• Pneumonia Aspiration in Unasyn (34 reports)
• Pneumonia Aspiration in Famotidine (137 reports)
• Pneumonia Aspiration in Cefazolin (34 reports)
• Pneumonia Aspiration in Rocephin (64 reports)
• Pneumonia Aspiration in Fentanyl Citrate (33 reports)
• Pulmonary Oedema in Unasyn (53 reports)
• Pulmonary Oedema in Famotidine (244 reports)
• Pulmonary Oedema in Cefazolin (113 reports)
• Pulmonary Oedema in Rocephin (135 reports)
• Pulmonary Oedema in Fentanyl Citrate (102 reports)
• Staphylococcal Infection in Unasyn (52 reports)
• Staphylococcal Infection in Famotidine (206 reports)
• Staphylococcal Infection in Cefazolin (102 reports)
• Staphylococcal Infection in Rocephin (130 reports)
• Staphylococcal Infection in Fentanyl Citrate (49 reports)

Could it be a symptom from a condition:

• Acute Respiratory Distress Syndrome (ARDS (acute respiratory distress syndrome)) in Pneumonia (124 reports)
• Acute Respiratory Distress Syndrome (ARDS (acute respiratory distress syndrome)) in Prophylaxis (170 reports)
• Hypersensitivity in Pneumonia (154 reports)
• Hypersensitivity in Prophylaxis (277 reports)
• Pneumonia Aspiration in Pneumonia (75 reports)
• Pneumonia Aspiration in Prophylaxis (78 reports)
• Pulmonary Oedema in Pneumonia (90 reports)
• Pulmonary Oedema in Prophylaxis (282 reports)
• Staphylococcal Infection in Pneumonia (81 reports)

Alternative drugs:

• Pneumonia (19 drugs) (updated 5 days ago)

Related drug interactions:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent drug studies on eHealthMe: